# Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus

> **NCT01915849** · PHASE1,PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 14 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** LIK066
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01915849
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01915849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01915849, "Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01915849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*